GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gennex Laboratories Ltd (BOM:531739) » Definitions » EV-to-FCF

Gennex Laboratories (BOM:531739) EV-to-FCF : (As of Apr. 16, 2025)


View and export this data going back to 2000. Start your Free Trial

What is Gennex Laboratories EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Gennex Laboratories's Enterprise Value is ₹2,829 Mil. Gennex Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0 Mil. Therefore, Gennex Laboratories's EV-to-FCF for today is .

The historical rank and industry rank for Gennex Laboratories's EV-to-FCF or its related term are showing as below:

BOM:531739' s EV-to-FCF Range Over the Past 10 Years
Min: -6.09   Med: 0   Max: 0
Current: -6.09

BOM:531739's EV-to-FCF is ranked worse than
100% of 546 companies
in the Drug Manufacturers industry
Industry Median: 23.125 vs BOM:531739: -6.09

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-04-16), Gennex Laboratories's stock price is ₹13.19. Gennex Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.812. Therefore, Gennex Laboratories's PE Ratio (TTM) for today is 16.24.


Gennex Laboratories EV-to-FCF Historical Data

The historical data trend for Gennex Laboratories's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gennex Laboratories EV-to-FCF Chart

Gennex Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -14.37 -37.36 9.49 -6.73 -6.94

Gennex Laboratories Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -6.94 - - -

Competitive Comparison of Gennex Laboratories's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Gennex Laboratories's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gennex Laboratories's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gennex Laboratories's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Gennex Laboratories's EV-to-FCF falls into.


;
;

Gennex Laboratories EV-to-FCF Calculation

Gennex Laboratories's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=2828.747/0
=

Gennex Laboratories's current Enterprise Value is ₹2,829 Mil.
Gennex Laboratories's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gennex Laboratories  (BOM:531739) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Gennex Laboratories's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13.19/0.812
=16.24

Gennex Laboratories's share price for today is ₹13.19.
Gennex Laboratories's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.812.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Gennex Laboratories EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Gennex Laboratories's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Gennex Laboratories Business Description

Traded in Other Exchanges
N/A
Address
Akash Ganga, Plot No. 144, 4th Floor, Srinagar Colony, Hyderabad, TG, IND, 500 073
Gennex Laboratories Ltd is engaged in the manufacturing of bulk drugs, and intermediates, Biotech Products. Geographically, the group has a business presence in Bangladesh, Egypt, Germany, Guatemala, Iran, Israel and other countries. Its products include Guaifenesin, Methocarbamol, Fluconazole and Phenazopyridine, among others.

Gennex Laboratories Headlines

No Headlines